MARATTO

article · Slovenian Veterinary Research

MOLECULAR CHARACTERIZATION, VIRULENCE, AND ANTIMICROBIAL SUSCEPTIBILITY OF MYCOPLASMA BOVIS ASSOCIATED WITH CHRONIC MASTITIS IN DAIRY COWS

2024Open accessMansoura University

Abstract

Mycoplasma bovis (M. bovis) is the most common Mycoplasma species, which has a growing impact on the dairy industry. The purpose of this study was to investigate the molecular characterization, virulence, and antibiotic susceptibility of M. bovis isolates from dairy cows with chronic mastitis in Egypt. Eighty-four composite milk samples from mastitic cows were aseptically collected from dairy farms in Egypt. Based on microbiological examination and the polymerase chain reaction (PCR) technique targeting the 16S rRNA, 14 (16.7%) of all milk samples were positive for Mycoplasma spp. PCR targeting M. bovis-specific gene identified six (7.14%) of the 14 mycoplasma isolates as M. bovis. PCR assays for different virulence genes showed that all M. bovis isolates exhibited the presence of vspA gene, while other virulence genes (uvrC, gap, and p40 pseudogenes) were determined in only two M. bovis isolates (2/6). The 16S rRNA gene phylogenetic analysis demonstrated 100% homology with reference strains of M. bovis isolated from different species and locations. When compared to other isolates in the GenBank, the amino acid sequence alignment of our isolate vspA-like protein indicated a distinct mutation. The in vitro antimicrobial susceptibility testing of the six M. bovis isolates in this study to seven antimicrobial drugs revealed that tilmycosin and tylosin had the lowest minimum inhibitory concentrations (MIC) values (≤1 μg/mL), while danofloxacin, streptomycin and florfenicol had the highest MIC values (

Research topics

  • Microbial infections and disease research
  • Bacteriophages and microbial interactions
  • Milk Quality and Mastitis in Dairy Cows

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.26873/svr-1882-2024

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.